Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Poultry

Immunological veterinary medicinal products, including vaccines, are authorised for poultry.

Search results 1 to 25 from a total of 136

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

AviPro AE

Aviäre Encephalomyelitis

Lohmann Animal Health GmbH

94a/89 20.07.1999 Huhn

Nobilis Influenza H5N2

Aviäre Influenza

Intervet International B.V., Niederlande

EU/2/06/061/001 - 004 01.09.2006 Huhn

EPAR: Nobilis Influenza H5N2

Vectormune HVT-AIV

Aviäre Influenza

Ceva Santé Animale, Frankreich

EU/2/25/335 28.03.2025 Huhn

EPAR: Vectormune HVT-AIV

Cevac Meta L

Aviäre Rhinotracheitis

Ceva Tiergesundheit GmbH

PEI.V.11806.01.1 31.10.2016 Huhn

Respivac TRT

Aviäre Rhinotracheitis

Laboratorios Hipra, S.A., Spanien

EU/2/24/314 30.05.2024 Huhn

EPAR: Respivac TRT

Nobilis RT+IB Multi+ G+ND

Aviäre Rhinotracheitis, Infektiöse Bronchitis, Infektiöse Bursitis, Newcastle-Krankheit

Intervet Deutschland GmbH

PEI.V.00380.01.1 08.07.1999 Huhn

Poulvac AE

Aviäres Encephalomyelitisvirus

Zoetis Deutschland GmbH

PEI.V.03600.01.1 05.02.2008 Huhn

Nobilis Multriva RT+IBm+ND+EDS

Aviäres Metapneumovirus, Infektiöse Bronchitis, Newcastle-Krankheit, Egg Drop Syndrom

Intervet International, B.V., Niederlande

EU/2/24/316 18.07.2024 Huhn

EPAR: Nobilis Multriva RT+IBm+ND+EDS

Nobilis Multriva RT+IBm+ND+Gm+REOm

Aviäres Metapneumovirus, Infektiöse Bronchitis, Newcastle-Krankheit, Infektiöse Bursitis, Aviäres Reovirus

Intervet International, B.V., Niederlande

EU/2/24/317 08.07.2024 Huhn

EPAR: Nobilis Multriva RT+IBm+ND+Gm+REOm

Nobilis Multriva RT+IBm+ND+Gm+REOm+EDS

Aviäres Metapneumovirus, Infektiöse Bronchitis, Newcastle-Krankheit, Infektiöse Bursitis, Aviäres Reovirus, Egg Drop-Syndrom

Intervet International, B.V., Niederlande

EU/2/24/309 06.05.2024 Huhn

EPAR: Nobilis Multriva RT+IBm+ND+Gm+REOm+EDS

Nobilis Multriva REOm

Aviäres Reovirus

Intervet International, B.V., Niederlande

EU/2/24/333 27.02.2025 Huhn

EPAR: Nobilis Multriva REOm

Nobilis Coryza

Coryza contagiosa

Intervet Deutschland GmbH

PEI.V.01765.01.1 13.03.2001 Huhn

Poulvac E. coli

E. coli-Infektion

Zoetis Belgium S.A., Belgien

EU/2/12/140/001-008 20.06.2012 Huhn

EPAR: Poulvac E. coli

Nobilis E. coli inac

E. coli-Infektion

Intervet Deutschland GmbH

283a/93 25.01.1995 Huhn

Nobilis EDS inac

Egg Drop-Syndrome

Intervet Deutschland GmbH

PEI.V.02859.01.1 12.08.2003 Huhn

HIPRAPOX

Geflügelpocken

Laboratorios Hipra S.A., Spanien

PEI.V.11803.01.1 13.11.2015 Huhn, Truthuhn

AviPro THYMOVAC

Hühner-Anämie

Lohmann Animal Health GmbH

220a/88 14.06.1999 Huhn

Nobilis CAV P4

Hühner-Anämie

Intervet Deutschland GmbH

12a/96 06.11.1996 Huhn

Vectormune FP ILT + AE

Hühnerpocken, Aviäre Infektiöse Laryngotracheitis, Aviäre Enzephalomyelitis

CEVA-Phylaxia Co. Ltd., Ungarn

EU/2/20/250 24.04.2020 Huhn

Vectormune FP ILT

Hühnerpocken, Infektiöse Laryngotracheitis

Ceva-Phylaxia Co. Ltd., Ungarn

EU/2/20/266 09.12.2020 Huhn

CEVAC IBird

Infektiöse Bronchitis

Ceva Tiergesundheit GmbH

PEI.V.11646.01.1 20.06.2013 Huhn

Poulvac IB H120

Infektiöse Bronchitis

Zoetis Deutschland GmbH

PEI.V.11696.01.1 18.12.2013 Huhn

Avishield IB GI-13

Infektiöse Bronchitis

GENERA Inc., Kroatien

PEI.V.11998.01.1 27.03.2020 Huhn

Nobilis IB Ma5

Infektiöse Bronchitis

Intervet Deutschland GmbH

PEI.V.11599.01.1 17.11.2011 Huhn

Poulvac IB QX

Infektiöse Bronchitis

Zoetis Deutschland GmbH

PEI.V.11668.01.1 12.04.2013 Huhn

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 17.06.2025